How to Help Your Patients Save Money on Vazalore: A Provider's Guide to Savings Programs

For patients on daily aspirin therapy for cardiovascular secondary prevention, Vazalore represents a clinically meaningful upgrade from standard aspirin formulations. But cost can be a barrier. Unlike generic aspirin — which costs just a few dollars for a 90-day supply — Vazalore retails for approximately $25–$45 per 30-count box, or $300–$540 annually. When an OTC medication costs that much, cost-related non-adherence becomes a real clinical concern.

As the prescribing clinician, you are often the most effective person to connect patients with savings resources. This guide covers every available savings pathway for Vazalore and how to communicate them efficiently at the point of care.

The Cost Challenge: Why Patients Stop Taking Vazalore

Cost-related non-adherence in chronic cardiovascular medications is well-documented. When patients face a choice between a $30–$45/month OTC medication and a generic aspirin costing $0.03 per day, many choose the less expensive option — even if the clinical evidence favors Vazalore for their profile. The patients most affected tend to be:

Medicare patients (OTC medications typically not covered by Part D unless prescribed)

Patients with high-deductible health plans who pay OTC costs out of pocket

Uninsured or underinsured patients with limited medication budgets

Strategy 1: Write a Prescription for Insurance Coverage

The most impactful single action a prescriber can take: write a prescription for Vazalore by name. While Vazalore is available OTC, a written prescription can unlock coverage through some insurance and Medicare Part D plans. Coverage and copays vary significantly by plan, but some patients may find their cost drops to $0–$15 with insurance when a prescription is present.

At the point of recommendation, consider routinely writing a prescription for Vazalore 81 mg #90 with refills — even for patients who don't initially ask for one. Advise them to bring the prescription to the pharmacy and ask if their insurance covers it. The two minutes it takes could save a patient hundreds of dollars annually.

Strategy 2: Advise Patients to Use GoodRx or SingleCare

For patients without prescription coverage, pharmacy discount programs offer significant savings:

GoodRx: Vazalore can be purchased for approximately $25.62 for a 30-count box with a GoodRx coupon — roughly 42% below the average retail price of $44.48.

SingleCare: Comparable pricing to GoodRx, with Vazalore available for approximately $24.66 per 30-count box at participating pharmacies.

Consider printing or displaying a QR code to GoodRx.com/vazalore in your waiting room or exam rooms. Many of your patients are unaware these programs exist and will benefit immediately from your referral.

Strategy 3: Educate Patients on FSA and HSA Eligibility

Aspirin — including Vazalore — is an IRS-qualified medical expense eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) purchases. Patients who have these accounts may already be paying Vazalore costs in after-tax dollars when they could be using pre-tax funds. Remind patients during the appointment:

"If you have an FSA or HSA through your employer, you can use those funds to buy Vazalore. That means you're effectively paying for it with pre-tax money, which can save you 20–30% depending on your tax bracket."

Strategy 4: Recommend Bulk Purchasing

Patients who can afford to buy a 90-day supply of Vazalore at once benefit from a lower per-capsule cost. This also addresses the supply variability problem — a patient with 90 days of medication on hand is not vulnerable to short-term pharmacy stockouts. When appropriate, advise patients:

"When you find Vazalore in stock, buy a 90-day supply. It's OTC, so there's no quantity limit. Amazon and Walmart often have 90-count bottles available."

Strategy 5: Manufacturer Savings Programs

Historically, PLx Pharma distributed high-value Vazalore coupons and samples through cardiology and primary care offices. Under current ownership by Greenwood Brands, similar programs may be available. Consider:

Checking vazalore.com for current patient savings programs

Contacting the manufacturer's medical affairs or sales team to request practice samples or savings cards

Providing patients with any in-office coupon materials for their first month's supply

Strategy 6: Clinical Cost-Benefit Conversation

For patients who balk at the cost of Vazalore even with savings, a brief clinical framing can help: the alternative — an aspirin-related GI bleed leading to hospitalization — costs tens of thousands of dollars. For high-risk patients with significant GI history on enteric-coated aspirin, Vazalore may be a cost-effective intervention when GI outcomes are factored in.

That said, this conversation requires clinical judgment. For low-risk patients without GI history, the pharmacoeconomic case for Vazalore over generic enteric-coated aspirin is less clear. Individualize your recommendation and savings conversation accordingly.

Strategy 7: Help Patients Find Vazalore When It's Out of Stock

Cost is not the only adherence barrier — availability is too. If patients can't find Vazalore, they'll default to whatever is available. Referring patients to medfinder helps them locate Vazalore in stock near them without spending hours calling pharmacies. Addressing both cost and access together is the most complete approach to optimizing Vazalore adherence.

Provider Action Summary: Vazalore Cost Reduction Checklist

Write a prescription for Vazalore 81 mg #90 with refills at each initial recommendation — regardless of whether the patient asks for one

Print or display a GoodRx/SingleCare reminder for Vazalore savings in your exam rooms

Remind patients to use FSA or HSA funds for Vazalore purchases

Advise bulk purchasing (90-day supply) to reduce per-unit cost and avoid stock gaps

Check vazalore.com for current manufacturer savings programs

Refer patients to medfinder to solve the supply availability problem alongside the cost problem